Using focused ultrasound to improve delivery of anti-cancer therapy for brain tumors
ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma
This study is exploring a new way to help treat glioblastoma by using focused ultrasound to open the blood-brain barrier, which could allow better delivery of a special therapy along with standard treatments, potentially giving patients more effective options for fighting this tough brain tumor.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11071947 on NIH RePORTER |
What this research studies
This research investigates a new approach to treat glioblastoma, a highly aggressive brain tumor, by using focused ultrasound technology to temporarily open the blood-brain barrier. This allows for better delivery of anti-CD47 immunotherapy alongside standard treatments. The study aims to evaluate how effectively this method can enhance the treatment of glioblastoma by improving the distribution of therapeutic agents within the tumor. Patients may benefit from this innovative technique that could lead to more effective treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are undergoing standard-of-care treatment.
Not a fit: Patients with other types of brain tumors or those who are not eligible for standard treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the effectiveness of treatments for glioblastoma patients by enhancing drug delivery to the tumor.
How similar studies have performed: Previous studies have shown promising results using focused ultrasound for drug delivery in brain tumors, indicating potential for success with this approach.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Malla, Adarsha Prakash — University of Maryland Baltimore
- Study coordinator: Malla, Adarsha Prakash
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.